EBVaGC comprises 5%–10% of gastric cancer cases and has several characteristics distinct from EBV-negative gastric cancers, such as massive lymphocytic infiltration, frequent genetic mutations in PIK3CA and ARID1A, and global hypermethylation of CpG islands [1, 2]. This evidence concerns the gene ARID1A and gastric cancer.